Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -42.22% is 36% below its 1-year average of -31.14%, near the low end of its 1-year range (-47.42%–0.00%).
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -45.98%.
OPERATING MARGIN
-42.22%
OPERATING MARGIN AVG TTM
N/A
OPERATING MARGIN AVG 3Y
N/A
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Alamar Biosciences, Inc.
Market Cap
$2.64B
Operating Margin
-42.22%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.64B
Operating Margin
-274.57%
TTM Avg
-464.41%
3Y Avg
-382.79%
5Y Avg
-92575.80%
Market Cap
$2.69B
Operating Margin
10.06%
TTM Avg
14.13%
3Y Avg
15.87%
5Y Avg
13.57%
Market Cap
$2.69B
Operating Margin
11.12%
TTM Avg
10.91%
3Y Avg
6.08%
5Y Avg
-3.97%
Market Cap
$2.51B
Operating Margin
-867.87%
TTM Avg
-840.98%
3Y Avg
-774.76%
5Y Avg
-1234.34%
Market Cap
$2.43B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.43B
Operating Margin
-0.74%
TTM Avg
-3.89%
3Y Avg
-12.55%
5Y Avg
-17.88%
Market Cap
$2.87B
Operating Margin
12.21%
TTM Avg
13.21%
3Y Avg
-4.78%
5Y Avg
-42.05%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alamar Biosciences, Inc. (ALMR) | $2.64B | -42.22% | N/A | N/A | N/A |
| Beam Therapeutics Inc. (BEAM)vs › | $2.64B | -274.57% | -464.41% | -382.79% | -92575.80% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | 10.06% | 14.13% | 15.87% | 13.57% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 11.12% | 10.91% | 6.08% | -3.97% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.51B | -867.87% | -840.98% | -774.76% | -1234.34% |
| Disc Medicine, Inc. (IRON)vs › | $2.43B | 0.00% | 0.00% | 0.00% | 0.00% |
| Clover Health Investments, Corp. (CLOV)vs › | $2.43B | -0.74% | -3.89% | -12.55% | -17.88% |
| AtriCure, Inc. (ATRC)vs › | $2.87B | 2.44% | -4.62% | -7.21% | -5.02% |
| TransMedics Group, Inc. (TMDX)vs › | $2.87B | 12.21% | 13.21% | -4.78% | -42.05% |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.88B | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
56.2%
Operating Margin
-42.2%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -45.98% |
| 2026-03-31 | -47.42% |
| 2025-12-31 | 0.00% |
